We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rockland Immunochemicals Awarded Phase II SBIR Funding

News   Oct 16, 2012

 
Rockland Immunochemicals Awarded Phase II SBIR Funding
 
 
 

RELATED ARTICLES

Pork Parasite Fought by Multipurpose Immune Pathway

News

Scientists have discovered that immune responses originally found to prevent fungal infections are also important in eliminating Trichinella spiralis, a round worm found in some under-cooked pork.

READ MORE

Kicking the Habit: Effectiveness of Different Forms of Nicotine Replacement Therapy

News

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

READ MORE

Blood Test Indicates Alzheimer's Drug Effect on Nerve Cell Loss

News

A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein in blood samples from patients with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE